BioSpace News Archive

Policy

Advocacy Group and FDA Advisor Call for a Moratorium on Opioid Approvals

As America continues to grapple with the opioid crisis, nonprofit advocacy group Public Citizen is calling for the U.S. Food and Drug Administration to place a moratorium on the approval of any new opioid medications.

March 22, 2019
·
3 min read
·
Alex Keown
Drug Development

Now, What’s Next in Alzheimer’s? For Biogen and Eisai, Another Phase III Trial

The debacle raised three broad questions: What will Biogen do next? Is the amyloid theory of Alzheimer’s now dead? And what else is going on in the Alzheimer’s drug development arena?

March 22, 2019
·
5 min read
·
Mark Terry
Job Trends

bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire

The manufacturing plant will produce lentiviral vector for its gene and cell therapies, including bb2121 and bb21217 for multiple myeloma and possibly LentiGlobin for transfusion-dependent beta-thalassemia (TDT) and sickle cell disease.

March 22, 2019
·
2 min read
·
Mark Terry
Pharm Country

J&J Takes $900 Million Loss as It Writes off RSV Drug Acquired in $1.7 Billion Alios Deal

In a filing with the U.S. Securities and Exchange Commission, Johnson & Johnson said it will abandon development of AL-8176, one of the assets it acquired in the Alios deal.

March 22, 2019
·
3 min read
·
Alex Keown
Biotech Bay

Biotechs by the Bay Boom With Business Bounty

When it comes to biotech and pharma innovation few places stand out like the Biotech Bay. The area is home to a plethora of innovative companies that are shaping the future of medical treatment for a variety of diseases and conditions on a daily basis.

March 22, 2019
·
4 min read
·
Alex Keown
Pharm Country

A Smart Toilet Seat to Detect Congestive Heart Failure

Researchers at the Rochester Institute of Technology have developed a toilet seat with biometric sensors in it. The primary purpose (the Number 1 purpose?) is to monitor an individual’s cardiovascular system.

March 22, 2019
·
4 min read
·
Mark Terry
Russia Opens the Door for Stem Cell Clinical Trials

The widespread global outreach potential of stem cell therapies is becoming apparent, especially given the recent news of a second person going into long-term remission (some saying “cured”) of HIV after undergoing a stem cell transplant.

March 22, 2019
·
4 min read
·
Chelsea Weidman Burke, M.S. with contributed content from OCT